We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate steady cash flows irrespective of market conditions. Mutual funds are perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Fidelity Select Pharmaceuticals Portfolio (FPHAX - Free Report) aims for capital growth. The fund invests the majority of its assets in securities of companies that research, develop and manufacture all types of pharmaceuticals and drugs. The non-diversified fund invests in securities of U.S. and non-U.S. issuers alike. FPHAX mostly invests in common stocks of companies. The fund has returned 12% in the past three years.
FPHAX has an expense ratio of 0.78% compared with the category average of 1.26%.
Franklin Biotechnology Discovery Fund Class A (FBDIX - Free Report) aims for capital growth. The fund invests the majority of its assets in the securities of biotechnology companies and discovery research firms. This non-diversified fund may also invest about a fifth of its assets in equity or debt securities of any type of issuer. The fund has returned 9.9% over the past three years.
Evan S. McCulloch is the fund manager of FBDIX since 1997.
T. Rowe Price Health Sciences Fund (PRHSX - Free Report) is a non-diversified fund that invests more than 80% of its assets in common stocks of companies engaged in various activities in the field of healthcare, medicine or life sciences. The fund mostly invests in mid- and large-capitalization companies. PRHSX has three-year annualized returns of 14.4%.
As of the end of June 2020, PRHSX held 153 issues with 5.73% of its assets invested in UnitedHealth Group Inc.
Image: Bigstock
3 Healthcare Mutual Funds to Make Beaucoup Money
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate steady cash flows irrespective of market conditions. Mutual funds are perfect choices for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below we share with you three top-ranked healthcare mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) or #2 (Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of healthcare funds, their Zacks Rank and past performance.
Fidelity Select Pharmaceuticals Portfolio (FPHAX - Free Report) aims for capital growth. The fund invests the majority of its assets in securities of companies that research, develop and manufacture all types of pharmaceuticals and drugs. The non-diversified fund invests in securities of U.S. and non-U.S. issuers alike. FPHAX mostly invests in common stocks of companies. The fund has returned 12% in the past three years.
FPHAX has an expense ratio of 0.78% compared with the category average of 1.26%.
Franklin Biotechnology Discovery Fund Class A (FBDIX - Free Report) aims for capital growth. The fund invests the majority of its assets in the securities of biotechnology companies and discovery research firms. This non-diversified fund may also invest about a fifth of its assets in equity or debt securities of any type of issuer. The fund has returned 9.9% over the past three years.
Evan S. McCulloch is the fund manager of FBDIX since 1997.
T. Rowe Price Health Sciences Fund (PRHSX - Free Report) is a non-diversified fund that invests more than 80% of its assets in common stocks of companies engaged in various activities in the field of healthcare, medicine or life sciences. The fund mostly invests in mid- and large-capitalization companies. PRHSX has three-year annualized returns of 14.4%.
As of the end of June 2020, PRHSX held 153 issues with 5.73% of its assets invested in UnitedHealth Group Inc.
To view the Zacks Rank and past performance of all healthcare mutual funds, investors can click here to see the complete list of funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>